Tag: nitrosamines

Addressing Unapproved Material Substitution in Deviation Investigations: A Playbook for Pharma Professionals In the pharmaceutical manufacturing landscape, unapproved material substitution during deviation investigations can pose critical compliance and safety risks.…

Mitigating Underestimated Change Impact During Routine Operations: A Playbook for CAPA Implementation In the dynamic landscape of pharmaceutical manufacturing, the impact of operational changes—no matter how routine—can often be vastly…

Strategies to Address Uncommunicated Specification Changes During Deviation Investigations In the complex landscape of pharmaceutical manufacturing, uncommunicated specification changes can jeopardize batch integrity and lead to costly recalls. The lack…

Tackling Documentation Gaps in Change Control During Supplier Transitions In pharmaceutical manufacturing, maintaining robust change control documentation is critical, particularly when transitioning to a new supplier for raw materials. Gaps…

Addressing Supplier Changes Not Evaluated During Post-Approval Reviews In the dynamic landscape of pharmaceutical manufacturing, managing supplier changes is critical to maintaining product integrity and compliance. A supplier change not…

Mitigating Risks of Unassessed Raw Material Changes During Post-Approval Reviews In the pharmaceutical manufacturing landscape, the integrity of raw materials forms the backbone of quality assurance and regulatory compliance. A…

Addressing Unapproved Material Substitutions in Pharma: A Practical Guide for Inspection Readiness Pharmaceutical manufacturing is fraught with complexities, particularly regarding raw material management. One of the most critical issues that…

Managing Raw Material Changes: A Playbook for Effective Deviation Investigations The pharmaceutical manufacturing landscape demands strict adherence to guidelines and regulations, particularly when it comes to handling raw materials. One…

Risk-Based Change Impact Assessment for Supplier Changes in Pharma Manufacturing In an environment where compliance is paramount, pharmaceutical manufacturers must remain vigilant regarding supplier changes. When a supplier change is…

Strategies for Managing Underestimated Change Impact in Pharmaceutical Deviations In the fast-paced world of pharmaceutical manufacturing, effective change control practices are paramount. Deviation investigations often reveal underestimated impacts of changes,…

Mitigating Risks from Unassessed Raw Material Changes Post-Approval In the pharmaceutical manufacturing landscape, compliance with regulations and rigorous documentation are paramount. A frequent challenge faced by professionals is the implementation…

Effective Strategies to Manage Unapproved Material Substitution During Regulatory Inspections In the pharmaceutical manufacturing landscape, the use of unapproved raw materials is a critical failure mode that can result in…